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Surgical Aspects
To quote the late Dr. Walter Dandy (1932) , "Tumours of the Hypophysis are among the most frequent, the easiest to recognize and the most satisfactory to treat of all intracranial tumours".
Tumours of pituitary origin, in fact, represent something approaching 30 % of all intracranial new growths (Love and Marshall, 1950) .
Sources of supply.-Patients suffering from disorders of the pituitary reach the neurosurgeon by way of a number of different specialists. The explanation for this is simply that the several functions of the gland are influenced to varied degrees, and the outstanding feature in the individual case directs the mode of enquiry. Thus the general physician may be called upon because of increasing adiposity or glycosuria, the gynmcologist for amenorrheea, the neurologist as visual disturbance or epilepsy develops, the ophthalmologist on account of visual deterioration and so on. The paediatrician, the endocrinologist and even the psychiatrist, each has some part to play.
Train of events.-Tumours of the pituitary were first described in the last decade of the nineteenth century (Horrax et al., 1955) but their clinical differentiation is of much more recent development. A somewhat circuitous course has taken place towards realization of outstanding clinical features of such diseases, amply illustrated by the way in which the interrelationship between amenorrhoea and pituitary dysfunction was fathomed. First, it became known that some girls in whom menstrual periods failed to appear in due course lost their vision. Deterioration of vision in such circumstances called for investigation which resulted in radiography of the skull. Some of the cases examined were found to have enlargement of the sella turcica, but this was not found invariably. Not until later was it realized that tumours above, or overlying, the sella turcica could bring about a like effect. Nowadays, with increasing knowledge about endocrine function the facts can be more fully determined.
NATURE OF TuMOURS
The fact that both intrasellar and suprasellar growths at times give rise to like symptoms and signs calls for further elucidation. The inference is that while certain disturbances of function are related to the nature of the responsible lesion, others depend upon its site. We know that some kinds of pituitary adenoma may spread in various directions, and also that other forms of tumour are to be found either in, or above, the sella turcica, depending upon the original position of the parent cells.
Reflection on the embryology of the pituitary gland helps one to comprehend the varied nature of its tumour formations. The pituitary gland originates from two ectodermal outgrowths: the one from the primitive nasopharynx that forms the anterior or adenomatous structure; the other from the diencephalon that gives rise to the posterior portion, or pars nervosa. Between these two segments lies a cleft, the remnant of the nasopharyngeal pouch.
From the anterior portion of the gland, and from the epithelial lining of the cleft quite different kinds of neoplasm arise:
(1) Tumours arising from the hypophysis.
(2) Tumours arising from the hypophyseal stalk or duct.
Tumours of the Hypophysis These are formed from the cellular components of the anterior lobe. As three different forms of adenomatous cell exist and these are recognizable as entities on their staining properties, so three different types of adenomatous tumour are to be met: adenoma of chromophobe, chromophil and basophil nature. These are, of course, pathologically innocent.
These three varieties of cell do not have the same propensity for new-growth formation. The chromophobe adenoma is about four times as common as the chromophilic type, whilst the basophil growth is very uncommon and usually of small, if not minute, proportions.
Not all tumours, however, conform with one or other type of cell; mixed cell types of adenoma do occur and moreover the largest pituitary tumours usually happen to be so constituted.
A proportion of the adenomatous growths do not remain within the sella, limited by the diaphragma sellb, but may extend in one direction or another. Even though a tumour be restricted within the stretched diaphragma selic it may encroach upon the visual pathways, but once it extends beyond the roofing membrane further disorders arise in its course. Any suprasellar extension is of paramount importance from the points of view of treatment and prognosis.
Such extensions may track in any of the following ways:
(1) Upwards towards the hypothalamus, whence headache, drowsiness and diabetes insipidus ensue.
(2) Laterally towards the cavernous sinus, to give rise to proptosis, chemosis, engorgement of orbital tissues and possibly interference with ocular mobility.
(3) Upwards and forwards to encroach upon, or even penetrate, the frontal lobe. As the outcome of this, personality change may ensue with loss of initiative, memory defect, and possibly epilepsy.
(4) Into the middle fossa with involvement of the temporal lobe indicated by uncinate attacks, mental disturbance and visual field defects from implication of the optic tracts.
(5) Into the orbit by direct invasion via the optic canal, resulting in proptosis, interference with ocular movement and diplopia.
(6) In a basal or pharyngeal direction as a consequence of which cerebrospinal rhinorrhoea may occur.
(7) Backwards into the interpeduncular space and even along the clivus to below the tentorium.
To such a degree may the effects of extension pervade the clinical picture that the primary source of the tumour can escape recognition. For instance, the writer has seen a mass excised from the frontal lobe with the conviction that a radical operation had been performed until histological examination of excised tissue revealed the source of the growth to be the pituitary gland.
From the surgical point of view, the risks of operation are much increased once a tumour escapes the precincts of the sella. What would be a straightforward intervention regularly followed by rapid recovery is apt to assume hazardous potentialities and a high mortality.
An interesting feature of the pituitary adenoma is the possibility of sudden hemorrhage within the capsule. It is a common belief that sudden and rapid deterioration of a patient's state, where he or she is the subject of an intracranial tumour, is to be explained on the basis of hlmorrhage into the tumour. In fact, such an event within brain tumours in general is not common, yet it is by no means exceptional in pituitary neoplasm. More than once has the writer reached hospital in the morning to operate on a case of pituitary adenoma, only to discover that the patient had succumbed overnight.
Another interesting experience was of a patient in whom sudden disturbance of visual acuity was followed by improvement within a few days. Mild pallor of the optic discs followed. This course of events was ascribed to disseminated sclerosis but proved to be due to a pituitary adenoma.
Hypophyseal Duct Tumours A number of different terms are in common use for new growth which arises from the remnants of Rathke's pouch. These include: craniopharyngioma, hypophyseal duct tumour, suprasellar cyst, adamantinoma, Rathke pouch tumour. This is said to be the commonest non-gliomatous tumour of the brain, accounting for about 4% of all intracranial tumours (Love and Marshall, 1950) .
As may be supposed from the various terms applied, this type of neoplasm may be found either within the sella, or above it. Suprasellar tumours occur at any time of life, but are most frequent during the second decade. Their rate of growth varies greatly, 50% developing in a few months, but the other 50% last from one to thirty years (Love and Marshall, 1950) . At each of two recent consecutive clinics an old patient reappeared after fifteen years: both have Rathke pouch tumours, both are still well and able to work. There seems to be little change in their physical states as judged in comparison with their prior condition.
Adenocarcinoma of the pituitary.-Malignant adenoma of the pituitary gland is rare; few authentic cases have been reported. The writer has met with one such case: A mass involving the sella, with destructive osteolytic changes on X-ray, was accompanied by dissemination involving vertebra, pelvis, omentum and the liver. It was considered strange that the general state of the patient did not deteriorate so rapidly as one might suppose, possibly because of destruction of the gland. The condition was of over six years' standing.
Pituitary abscess.-From time to time a condition is found at operation wherein an encapsulated collection of material macroscopically resembling pus is evacuated from the region of the sella turcica. Thick, yellowish, pultaceous or creamy material is found. The underlying pathology is not of an inflammatory nature but neoplastic, appearing to be formed of degenerated tumour, either adenomatovs or adamantinomatous in character.
The contents are just structureless debris. SYMPTOMATOLOGY It is not intended to present an intimate citation of the manifestations exhibited by the various tumours of pituitary origin but it would not be opportune wholly to ignore the matter.
Adenomas.-As the cellular structure is varied, so is the influence on pituitary functions. Whereas the chromophobe adenoma tends to induce a picture of pituitary insufficiency, the chromophilic tumour gives rise to a state of hyperactivity of the gland.
The gland's normal functions being related to growth, sexual control, metabolism, and skin and hair development, features such as diminished sexual activity, diminution of hair growth with restricted necessity for shaving, and a tendency to lassitude attend diminished pituitary activity. The blood pressure is often low.
The chromophilic tumour influences growth, to produce gigantism or acromegaly according to whether the period of activity precedes or follows union of the epiphyses.
The basophil adenoma is responsible for some cases of Cushing's syndrome. Upon this there is no necessity to dilate for it plays little part in the main theme of the paper.
Rathke pouch tumours are not so intimately tied up with endocrine disorder as are the adenomata. Encroaching as they do upon the hypothalamus, they may well cause disorder of metabolism. Involvement of the tuber cinereum results in the state known as dystrophia adiposogenitalis, and interference within the supra-optic nucleus leads to diabetes insipidus.
An outstanding feature of the Rathke pouch tumour is its tendency to undergo calcification; an appearance results on X-ray that may be said to be pathognomonic. Perhaps 70 to 80% show calcific deposits ( Fig. 1 ). Where these changes are not present it may be difficult to be sure whether alterations in the sella are due to an immediate tumour, or the outcome of dilatation of the third ventricle in relation to a generalized hydrocephalus. Indeed, differentiation between a suprasellar tumour and even a subtentorial lesion may require investigation by ventriculography (Fig. 2) .
The basic symptomatology of the Rathke pouch tumour varies with the age of the patient.
In early life, growth disturbance and increasing intracranial pressure engage attention.
During the intermediate decades, endocrine and metabolic disorders are outstanding symptoms; in yet older patients, visual disturbance is usually the guide.
DIFFERENTIAL DIAGNOSIS
Where surgery applies attention must be focused on interference with vision and/or disturbances of intracranial pressure. A number of pathologies other than new growth of pituitary origin need to be considered if avoidable errors are not to be made, and their differentiation from pituitary growth is attendant on clinical, radiographic and other investigations ( Fig. 3) . Of such pathological conditions may be mentioned the following: Pituitary adenoma, Rathke pouch tumour, suprasellar meningioma, dermoid and epidermoid tumours, glioma of the optic chiasma, adenocarcinoma of the pituitary, metastatic carcinoma, aneurysm (especially of the anterior communicating artery), chiasmal arachnoiditis, chiasmal injury. It is not proposed that the establishment of each individual pathology should be subject to discussion. Suffice it to say that a pre-operative pathological diagnosis should be determinable in a large majority of cases.
TREATMENT It was Harvey Cushing's practice to operate on patients suspected of having a pituitary tumour only where vision was involved or obstruction to the cerebrospinal fluid pathways occurred (Henderson, 1939) . I would suggest that it is not merely involvement of the visual tracts that determines the issue, rather is it progressive involvement, for one encounters a number of patients manifesting definitive visual field disorders who yet can carry on undisturbed and undisabled over many years without treatment. Quite recently the writer has encountered two cases of twenty-five years' standing, one with bitemporal hemianopia.
In neither case does there appear to have been any deterioration of note.
It is not my intention to go into the various methods and Toutes of surgical intervention. What one wishes to convey is the necessity for surgery where a patient is progressively affected and the general health is of a quality that justifies the necessary procedure.
First of all, at the present time one does not operate for endocrine disorder alone. Where surgery is indicated, it should be considered as a primary measure, not merely a subsidiary, applied only where irradiation has failed. My reasons for this decision are:
(a) Cystic tumours do not respond to irradiation. It is not possible on clinical or radiological data to say whether in a given case the actual lesion is cystic or solid.
(b) Tumours of Rathke pouch origin are not responsive to high voltage therapy. Therefore, where the nature of the tumour remains in doubt, only surgery is permissible.
(c) Series as reported by Horrax et al. show an unsatisfactory response to initial deep therapy, 58 out of 99 cases being inadequately responsive (Horrax et al., 1955) .
(d) High voltage therapy may have disastrous effects. This may be ascribable to technique and therefore avoidable.
My personal opinion is that operation should be given primary consideration where it applies, but that a course of teletherapy should follow. In support of this I would like to say that for the last twenty-five years it has been my practice to treat cases of adenoma of the pituitary in this way. During the early part of World War II deep therapy was not generally available to us. As a result, cases I should prefer to reserve primary irradiation for cases where the tumour has escaped beyond the sella, circumstances seriously affecting the mortality and morbidity of surgical intervention.
A brief historical survey of the treatment of pituitary tumours by irradiation during the past fifty years was outlined. The clinical response of pituitary adenomas in the early years was disappointing, which was not surprising in view of the inadequate facilities available and scanty knowledge of dosimetry compared to modem-day standards. With the high development of surgical technique, particularly through the intracranial approach by the Harvey Cushing school, such promising results followed that surgery became the accepted method of treatment. Although Cushing himself predicted that radiotherapy would come to be discarded in the treatment of chromophobe adenomas, Henderson (1939) in his most comprehensive monograph based on a review of Cushing's large series of cases revealed that the patients who had received post-operative X-ray therapy had a most significant percentage increase of the five-year periods without recurrences.
Increasing use of radiotherapy.-During the past twenty years many reports of series of cases of pituitary adenomas both chromophobe and chromophil have been published which clearly establish the relative radiosensitivity of these tumours. Certainly in several North American neurosurgical units the pendulum has swung to the opposite side in that these adenomas are treated by irradiation in the first instance and only those cases which prove refractory to the therapy or show signs of further visual impairment are subsequently explored.
Hazards of radiotherapy.-It was shown that tumour regression bore a definite relation to the dosage of radiation delivered to the tumour. In general, the higher the dosage the more impressive the immediate response, but unfortunately it is only in relatively recent years that a full appreciation of the vulnerability of the tissues of the central nervous system to ionizing radiations has come into clear focus. There can be little doubt that many patients have met with premature death as a direct result of irradiation damage to the neighbouring brain tissue, particularly to the hypothalamic region which is in immediate anatomical relation to the pituitary.
Unfortunately, irreversible effects can be produced by dosages of radiation not greatly in excess of those considered to be at a safe therapeutic level. In illustration, oneunfortunate case in the series was quoted:
A woman of 55 had a confirmed chromophobe adenoma partially excised and followed by X-ray treatment. For some unaccountable -reason the dosage of X-rays prescribed was 4,500 r instead of the customary maximum level of 4,000 r in four weeks. The patient made satisfactory progress until one year later when she developed headache, associated with deterioration of vision. This progressed to drowsiness and disorientation when she was readmitted to the National Hospital, Queen Square, under the care of Dr. E. A. Carmichael and Mr. Wylie McKissock. It was thought that she might have arachnoiditis of the chiasmal region, and craniotomy was performed in an attempt to relieve this. The patient's condition deteriorated, however, and she died a few days later with hyperthermia and low blood pressure.
Autopsy was performed by Dr. W. Blackwood and definite post-irradiation changes were demonstrated in the hypothalamus which could account for the patient's death. [Slides prepared by Dr. Blackwood were shown to illustrate the macroscopic and iicroscopic changes in the involved region of the brain.]
Advantages of combined surgical and radiation treatment.-In this country it is common practice to perform preliminary surgical exploration and partial excision of the adenoma. The advantages may be enumerated:
(1) This permits immediate decompression of the visual pathways. Permanent blindness may occur in a relatively short period of time in a proportion of cases which do not respond to primary irradiation.
(2) A direct assessment of the size and extent of the adenoma can be made. Excision of a large proportion of the tumour alows irradiation to be concentrated on a much smaller volume of tissue and permits standardization of the technique.
(3) Histological verification of the tumour can be obtained. It is well known that other conditions may simulate the "pituitary syndrome", e.g. a tumour in the posterior fossa causing dilatation of the third ventricle, a meningioma or glioma in relation to the clinoid processes, an aneurysm of the circle of Willis, a suprasellar cyst, or even a localized metastasis.
The disadvantage of surgery lies in the operative mortality which fortunately is now extremely low in the hands of experienced neurosurgeons.
Review ofPersonal Series of Cases A total of 220 patients who have received radiotherapy during the past fourteen years came under review and Table I indicates the various pathological groups. The average age of the patients was 43-1 years and the age range 17-70 years. There were 122 (55%) males and 98 (45%Y.) females. The chromophobe adenomas form the largest group in this series and the subsequent discussion will be confined mainly to these tumours. It is common to find a relatively high proportion of eosinophil tumours but it will be noticed that some of the chromophobe adenomas are labelled "mixed" cell tumours.
Delay in Diagnosis of Chromophobe Adenomas
The life-history of these tumours usually extends over many years and if the accompanying degree of hypopituitarism is low then visual impairment alone brings the patient under investigation. Nevertheless it should be possible to refer a proportion of these cases for treatment at much earlier periods. This applies particularly to women for in this series no less than 41 female patients in a total complement of 78 women gave a history of early menopause. The average interval from the time of cessation of periods until presenting for treatment is calculated at 7-5 years. In women with unexplained amenorrhoea even a simple lateral radiograph of the skull may lead to the correct diagnosis in many instances. Fno. 1 is a radiograph of a young married woman of 21 years. Her periods commenced at 11 years and stopped at 16 years. She attended a women's hospital on two occasions and was duly reassured. Subsequently she developed headaches, associated with diplopia. She received a course of radiotherapy one year ago for suspected pituitary adenoma. To-day she is well and her periods have returned. Fig. 1 shows considerable expansion of the sella.
Early diagnosis of chromophobe adenomas in men is more difficult, but the following case is of interest. It is most unusual to find a radiographically normal sella when a chromophobe adenoma is diagnosed. In the series under review the only instance occurred in a woman of 47 with an adenoma which had herniated through the diaphragma sellie resulting in visual impairment.
Principles of Radiotherapeutic Technique I shall discuss only the basic principles of method employed. One cannot overstress the importance of confining the zone of maximum dosage of radiation to the pituitary region and careful attention must be given to the question of beam direction. All the cases in the present series have been treated by conventional X-ray therapy using a beam of half value layer 3 mm.Cu. Five 4 cm. square fields are directed by means of a Perspex jig which rotates through the "pituitary axis". This axis is carefully checked by radiographic control using the treatment beam reduced to 90 kV.
[A series of slides was shown indicating the design of the treatment jig, and showing the patient "set up" in position for treatment. Dosage contours with five and eight field distributions were also illustrated.]
The dosage of radiation prescribed under the above conditions is 3,750 r maximum in four weeks. The prescribed dose was recently reduced from 4,000 r given in the same period.
With this method the skin at the treatment areas develops a mild erythema only and there is practically no constitutional disturbance. I consider that the method is more readily controlled than by any form of rotation therapy. Also, as the bone absorption factor in the relatively thin membrane bone of the skull is practically negligible there would not appear to be any particular advantage in employing supervoltage therapy in this situation.
Response to Treatment
Chromophobe adenomas.-Following the combined surgical and X-ray treatment, of the total of 165 patients comprising the series of chromophobe adenomas, 49 showed marked visual improvement in terms of full return of visual acuity and clearing of visual fields; 95 showed moderate visual improvement, and 21 showed no improvement.
The assessment was made up to a period of six months following the completion of the treatment, because the amelioration was sometimes delayed. In short, 87 % of the treated cases showed some form of visual improvement.
The endocrine changes in chromophobe adenomas due to hypopituitarism are more difficult to assess. In many patients these changes were relatively modest and almost subclinical in type. In a smaller number the symptoms of obesity, somnolence, hypotension, pallor and extreme weakness were severe, leading to profound states of hypopituitarism.
Obviously, apart from surgery and radiotherapy the institution of endocrine replacement therapy by such agents as cortisone, thyroid and testosterone, is of the greatest importance. Fortunately, during recent years much more attention is being given to this side of the problem, as Dr. Leonard Simpson will indicate.
Eosinophil tumours.-The response to treatment is rather more difficult to assess, as a proportion of the cases are not associated with visual impairment. It would appear that the acromegalic process may be arrested by the irradiation, but it is not common for the characteristic facial features to change to any extent.
Basophil tumours.-All patients except one in this group showed some degree of improvement, and in three instances the improvement was striking.
[Slides were shown to illustrate the dramatic improvement occurring in two patients.] Craniopharyngiomas.-The response to irradiation is decidedly encouraging in some cases. These tumours are by no means radio-insensitive as a class.
Carcinoma.-Although primary carcinoma of the pituitary is an uncommon disease, it is probably not so rare as is generally believed. There is increased evidence to show that the more cellular chromophobe adenoma can assume a malignant change. This has occurred in 3 of the patients in this group. 2 have died from intracranial metastases: one developed a large secondary growth in the right hemisphere, and the other separate masses over the meninges in the posterior fossa. 3 of the patients had original chromophobe adenomas which had become frankly malignant; the remainder were probably malignant from the outset.
Results Expressed in Survival Rates As these tumours are for the most part non-malignant and occur in a relatively young age group, one would expect the survival rates to be high. Tables II and III Study of Deaths It is important to investigate the causes of death in the unsuccessful cases. There were 20 deaths in the series, and as far as can be ascertained the causes are enumerated:
(1) Intracranial extension of recurrent adenomas-6 patients.
(2) Extreme hypopituitarism-6 patients.
(3) Malignant transition in tumour-1 patient.
(4) Post-irradiation changes in brain-3 patients. In conclusion it may be said that nowhere in the field of tumour treatment can radiotherapy combined with surgery give more promising results, and nowhere can the consequences be more serious unless the greatest care is given to the details of technique and clinical management. REFERENCE HENDERSON, W. R. (1939) Brit. J. Surg., 26, 811. Dr. S. Leonard Simpson (London) :
Endocrine Aspects
In my brief observations, I shall consider two main types of pituitary tumour, chromophobe tumours with pituitary hypofunction, and eosinophil tumours with hyperfunction, acromegaly or gigantism, often combined with some aspects of pituitary hypofunction.
DIAGNOSIS
Chromophobe tumours.-These may remain unrecognized for ten or more years, and may present in limited form. Thus, one man of 51 had loss of libido and potency for sixteen years with progressive adiposity. Ultimate radiography of the skull for migraine showed extensive destruction of the sella turcica although changes in the fundi and visual fields were almost absent. Another man of 60 was treated for eight years with liver and iron for severe anmmia and much greater pallor, before visual impairment led to the correct diagnosis. Amenorrhcea, myxoedema, and migraine are other erroneous primary diagnoses which have been maintained for many years, in the absence of fundus examination and X-ray of the skull. Radiography is essential, as a tumour may be extensive with normal fundi. A simple lateral view of the skull is usually sufficient. The easiest way to avoid pitfalls of diagnosis, as above, is for the clinician always to bear in mind the possibility of insidious development of chromophobe adenoma. I have not dealt with the more conventional symptoms of clinical pituitary hypofunction, e.g. anorexia, weakness, sensitivity to cold, &c., but would refer briefly to a number of laboratory tests based also on an associated secondary failure of adrenal and thyroid function, e.g. very low urinary values for 17-ketosteroid and 17-ketogenic steroids, low blood 1 I-oxysteroids, all three responding to ACTH stimulation except in some long-standing cases, insulin hypersensitivity or hypoglycvmic unresponsiveness, poor excretion of water load but corrected by cortisone, poor radioactive iodine uptake by involuted thyroid, &c.
Acromegaly.-Here also diagnosis may be delayed for many years, and clinical presentation may lead to a wrong or limited diagnosis. Two acromegalic women had large colloid goitres surgically removed fifteen and eight years before acromegaly was diagnosed, one being re-operated upon for recurrence. There is a definite association between such goitres and both gigantism and acromegaly, of practical and theoretical importance. Three women presented as idiopathic hirsutism. Cushing pointed out that the adrenals are often very large and nodular in acromegaly. Migraine and/or excessive perspiration may present for many years before true diagnosis. Impotence and/or azoospermia may be the only recognized features for some ten years, and one such patient referred from a sterility clinic became fertile and the father of two children after radiotherapy by Professor B. W. Windeyer. Sexual precocity or excessive sexual drive is a rare initial manifestation of acromegaly, but pituitary tumour is not a cause of a persistent syndrome of sexual precocity without acromegaly.
Rapid growth in childhood may be a precursor of acromegaly in later life. Cushing (1912) described very rapid growth in a male at 13, no acromegaly at 25, but death with acromegaly and eosinophil tumour at 32. I have seen a case of a girl with acromegaly, first obvious at 13, who had become suddenly tall at 5, 56 inches compared with average of 44 inches, very strong and a deep voice like the headmaster. Fundi known to be normal at 11. At 13, 6 ft. 6 in., 230 lb., fat abdomen, optic atrophy and bilateral hemianopsia. At 16, 6 ft. 10 in.; at 19, 7 ft. and 20 st. This is a sad example of mistaken masterly inactivity based upon the fallacious reasoning that the disease was quiescent because the fundi and fields remained the same from the age of 13. It is of interest that uncles and grand-uncles were over 6 ft., very strong and adipose, one a blacksmith weighing 40 st. Adiposity is not a common characteristic of acromegaly but it is a feature in some, and is probably associated with pancreatic islet cell hyperplasia, unless an extensive tumour invades the hypothalamus. Mild gigantism with slight acromegaly is familial, but two tall women with gross acromegaly had many gigantic males in the family, 6 ft. 4 in. or more in height, but without gross acromegaly. TREATMENT The discovery and availability of cortisone, hydrocortisone and prednisone have made substitution therapy for pituitary hypofunction more comprehensive, and, in particular, have made surgery of the pituitary gland a much safer procedure, endocrinologically speaking, in the same way as they have made bilateral adrenalectomy a practical and safe procedure. It seems prudent to give one of these substances before operation and to continue after operation until the need for and amount of a maintenance dose is decided. In so far as aldosterone secretion persists after hypophysectomy (Maclean et al., 1957) , except perhaps in some long-standing cases, prednisone seems to be slightly preferable to cortisone in that its sodium-retaining action is negligible. Cortisone has the advantage over prednisone for the operative period, of being available for intramuscular injection as well as by the oral route, and hydrocortisone in alcoholic solution or in the form of the watersoluble succinate can be given intravenously, the latter directly in small volume, 100 mg. in 2 ml. Although pituitary operations were frequently successful prior to the era of cortisone, some patients collapsed and died after relatively minor surgical interference, and cortisone diminishes this hypersensitive reaction of pituitary-insufficient cases to minor and major surgery.
For substitution therapy, in hypopituitarism both before and after operation, testosterone and thyroid are important adjuncts to prednisone. Unlike its negligible effect in Addison's disease, testosterone by itself has a valuable and often dramatic effect in pituitary hypofunction as was illustrated by two cases of surgically treated pituitary chromophobe tumour reported to the Society (Simpson and Taylor, 1947; Simpson and Wright, 1947) , as well as in a series of cases of Simmonds's disease (Simpson, 1948) . One of these tumour patients, now 79, on methyltestosterone, is so well and so youthful as to suggest hypophysectomy as a routine procedure for rejuvenation and longevity. Neither cortisone nor testosterone should be given in doses above the minimum required to obtain clinical results, as large doses are disturbing, especially in the case of prednisone or cortisone.
Prednisone is especially valuable in those patients who tend to hypoglyctmia, anemia (Summers, 1952) , or water intoxication. Adrenocorticotrophic hormone (ACTH) is a logical alternative to prednisone and testosterone combined, but has the disadvantages of requiring daily injections, producing side reactions in some, being ineffective after a while because of antibodies, or failing to secure an adrenal response in long-standing cases. Pituitary growth hormone is not yet available and, apart from the disadvantages of injections, is not essential except perhaps for skeletal growth, testosterone being protein anabolic.
(Estrogens in large doses are clinically effective in some patients with acromegaly, and can diminish pituitary diabetes and improve visual fields (McCullagh et al., 1955) , but fundamentally I consider them to be of limited value. In gigantism in adolescent girls, cestrogens accelerate union of the epiphyses.
Both for purposes of diagnosis and for determining treatment, it is valuable to have laboratory aids to clinical judgment as to the activity of an acromegalic process, or, in other words, the extent of hypersecretion of growth hormone. Raised inorganic phosphorus (Li et al., 1949) and increased urinary creatine or creatinine excretion are simple but somewhat unreliable indications. The measurement of plasma insulin by uptake of glucose by the rat's isolated diaphragm (Randall, 1954; Randall and Young, 1956 ) is, in my clinical experience, of considerable value and reliability when carried out under tested conditions and compared with a pool of normal plasma. This test is in keeping with the important post-mortem findings of Cushing and Davidoff (1927) of the frequency of pancreatic islet cell hyperplasia and hypertrophy in acromegaly, and is supported by animal experiments with growth hormone.
Finally, the need for surgery, or radiotherapy, in acromegaly should not be determined solely by encroachment on the fundi and visual fields. Clinical and biological evidence of progressive pituitary hyperfunction is at least of equal importance now that substitution therapy for any subsequent pituitary hypofunction is on a sound basis. It is well known in endocrinology that the degree of hyperfunction is not related to the size of an endocrine neoplasm.
